The inhibition of ovary testis transcribed isoform X1, a protein likely involved in crucial cellular processes, can be achieved through the targeted disruption of various signaling pathways and enzymatic activities. Chemical inhibitors such as Staurosporine, LY294002, Wortmannin, Dasatinib, Erlotinib, Imatinib, and Lapatinib play pivotal roles in this inhibition by targeting key proteins and pathways that regulate or influence the activity of ovary testis transcribed isoform X1. Staurosporine, a broad-spectrum protein kinase inhibitor, prevents phosphorylation, a critical post-translational modification necessary for the activation or functional modification of ovary testis transcribed isoform X1. LY294002 and Wortmannin, both inhibitors of PI3K, disrupt signaling pathways that are essential for the activity of ovary testis transcribed isoform X1, leading to its functional inhibition. This demonstrates the importance of the PI3K pathway in regulating processes that ovary testis transcribed isoform X1 may be involved in.
In addition to these, Rapamycin's inhibition of the mTOR pathway directly impacts protein synthesis and cellular growth processes, which are vital for the functional expression or post-translational modifications of ovary testis transcribed isoform X1. PD98059, SB203580, SP600125, and U0126 target the MAPK/ERK, p38 MAPK, and JNK pathways, respectively. These pathways are involved in various cellular processes, including stress responses and regulation, which are likely important for the functionality of ovary testis transcribed isoform X1. By inhibiting these pathways, these chemicals lead to a decrease in the functional activity of ovary testis transcribed isoform X1. Erlotinib, Imatinib, and Lapatinib, as tyrosine kinase inhibitors, further contribute to the inhibition by targeting EGFR, BCR-ABL, c-Kit, PDGFR, and HER2/neu, which are involved in signaling pathways crucial for the function of ovary testis transcribed isoform X1. The inhibition of these kinases leads to a reduction in the functional activity of ovary testis transcribed isoform X1 by disrupting the signaling cascades crucial for its functional state. Thus, the collective action of these inhibitors, through their specific targets, contributes to the functional inhibition of ovary testis transcribed isoform X1, demonstrating the intricate interplay between cellular signaling pathways and protein functionality.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine inhibits protein kinases, which are crucial for the phosphorylation of ovary testis transcribed isoform X1, preventing its activation or functional modification. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, disrupting pathways essential for the activity of ovary testis transcribed isoform X1, leading to its functional inhibition. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits the mTOR pathway, affecting protein synthesis and cell growth, essential for the functional expression of ovary testis transcribed isoform X1. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 inhibits MEK in the MAPK/ERK pathway, potentially reducing ovary testis transcribed isoform X1's activity by lowering ERK activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580, a p38 MAPK inhibitor, decreases the functional activity of ovary testis transcribed isoform X1 by affecting stress response pathways. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits JNK, reducing ovary testis transcribed isoform X1's activity by impacting cellular processes it may be involved in. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 inhibits MEK1/2 in the MAPK/ERK pathway, leading to reduced activity of downstream targets including ovary testis transcribed isoform X1. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, a PI3K inhibitor, disrupts signaling pathways, leading to the functional inhibition of ovary testis transcribed isoform X1. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib, a tyrosine kinase inhibitor, reduces the activity of ovary testis transcribed isoform X1 by affecting relevant signaling pathways. | ||||||
Erlotinib, Free Base | 183321-74-6 | sc-396113 sc-396113A sc-396113B sc-396113C sc-396113D | 500 mg 1 g 5 g 10 g 100 g | $87.00 $135.00 $293.00 $505.00 $3827.00 | 42 | |
Erlotinib inhibits EGFR tyrosine kinase, which is important for ovary testis transcribed isoform X1's function, leading to its reduced activity. | ||||||